Literature DB >> 31630236

The coexistence of gout in ankylosing spondylitis patients: a case control study.

Tal Gonen1, Shmuel Tiosano1,2, Doron Comaneshter3, Howard Amital1,2, Arnon D Cohen3,4, Ora Shovman5,6.   

Abstract

Ankylosing spondylitis (AS) and gout are common inflammatory arthropathies. It had been claimed previously that the two conditions rarely coexist. The aim of this study was to compare the prevalence of gout in a population of AS patients to its prevalence in the general population. To conduct this population-based case-control study, data of adult patients with a physician diagnosis of AS were retrieved from the database of the largest health-care provider organization in Israel, Clalit Health Services. For each patient with AS, five age- and sex-matched subjects without AS were randomly selected from the same database. Different parameters including the existence of gout, hypertension, body mass index, socioeconomic status, and smoking were evaluated in both the AS and the control groups. The study included 3763 patients with AS and 19,214 controls. The proportion of gout in the AS group was higher than in the control group: 73 subjects in the AS group had gout, while only 107 subjects in the non-AS group had gout (1.94% and 0.56%, respectively, OR 3.53, P < 0.001). Logistic regression adjusting for possible confounding variables found that AS was independently associated with gout (OR 1.41, P = 0.037). Our study suggests that gout is not less common in AS patients in comparison with the general population, and that it might even be more common in AS patients.

Entities:  

Keywords:  Ankylosing spondylitis; Case–control study; Comorbidities; Gout; Rheumatic diseases

Mesh:

Year:  2019        PMID: 31630236     DOI: 10.1007/s00296-019-04462-x

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  29 in total

1.  Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis.

Authors:  Ernst Feldtkeller; Muhammad Asim Khan; Désirée van der Heijde; Sjef van der Linden; Jürgen Braun
Journal:  Rheumatol Int       Date:  2002-09-03       Impact factor: 2.631

2.  Coincidence of ankylosing spondylitis, gouty arthritis and chondrocalcinosis articularis.

Authors:  J Duda; J Rovensky; H Tauchmannova; J Bakosova
Journal:  Isr Med Assoc J       Date:  2005-10       Impact factor: 0.892

Review 3.  Global prevalence of ankylosing spondylitis.

Authors:  Linda E Dean; Gareth T Jones; Alan G MacDonald; Christina Downham; Roger D Sturrock; Gary J Macfarlane
Journal:  Rheumatology (Oxford)       Date:  2013-12-09       Impact factor: 7.580

Review 4.  Ankylosing Spondylitis and Axial Spondyloarthritis.

Authors:  Joel D Taurog; Avneesh Chhabra; Robert A Colbert
Journal:  N Engl J Med       Date:  2016-06-30       Impact factor: 91.245

Review 5.  Global epidemiology of gout: prevalence, incidence and risk factors.

Authors:  Chang-Fu Kuo; Matthew J Grainge; Weiya Zhang; Michael Doherty
Journal:  Nat Rev Rheumatol       Date:  2015-07-07       Impact factor: 20.543

6.  Gout and osteoarthritis: a pathogenetic link?

Authors:  Edward Roddy; Michael Doherty
Journal:  Joint Bone Spine       Date:  2012-08-03       Impact factor: 4.929

Review 7.  Gout and Metabolic Syndrome: a Tangled Web.

Authors:  Gabrielle E Thottam; Svetlana Krasnokutsky; Michael H Pillinger
Journal:  Curr Rheumatol Rep       Date:  2017-08-26       Impact factor: 4.592

8.  Coexistent acute gouty arthritis and ankylosing spondylitis. A rare occurrence.

Authors:  D M Wong; I M Chalmers
Journal:  J Rheumatol       Date:  1994-04       Impact factor: 4.666

9.  Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study.

Authors:  Hyon K Choi; Karen Atkinson; Elizabeth W Karlson; Gary Curhan
Journal:  Arch Intern Med       Date:  2005-04-11

10.  All disease begins in the gut: Celiac disease co-existence with SLE.

Authors:  Shani Dahan; Dana Ben-Ami Shor; Doron Comaneshter; Dorit Tekes-Manova; Ora Shovman; Howard Amital; Arnon D Cohen
Journal:  Autoimmun Rev       Date:  2016-06-11       Impact factor: 9.754

View more
  1 in total

1.  The interplay between HLA-B and NLRP3 polymorphisms may be associated with the genetic susceptibility of gout.

Authors:  Javier Fernández-Torres; Gabriela Angélica Martínez-Nava; Karina Martínez-Flores; Roberto Sánchez-Sánchez; Luis J Jara; Yessica Zamudio-Cuevas
Journal:  Mol Biol Rep       Date:  2022-09-03       Impact factor: 2.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.